Press Releases
Cyxone Initiates Feasibility Preclinical Studies to Optimize Path Forward for Multiple Sclerosis Drug Candidate T20K
6 May, 2021 16:15 CESTWorld leading rheumatology authority Professor Costantino Pitzalis collaborates with Cyxone on Rabeximod Phase 2b study
4 May, 2021 08:47 CESTNotice of annual general meeting in Cyxone AB
4 May, 2021 08:31 CESTRegulatoryCyxone presents at BioStock Live 9 March 2021
3 Mar, 2021 14:10 CETCyxone's presentation at Aktiedagen 27 January now published
28 Jan, 2021 09:12 CET